Singapore handles adverse event reports post-drug registration through the Health Sciences Authority (HSA). The HSA collects, evaluates, and monitors these reports via its Vigilance and Compliance Branch, ensuring drug safety. Healthcare professionals and consumers can report adverse reactions through the HSA’s online system, contributing to ongoing pharmacovigilance.
